Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

48.17
-1.1800-2.39%
Pre-market: 47.80-0.3700-0.77%06:25 EDT
Volume:5.85M
Turnover:284.22M
Market Cap:97.43B
PE:15.40
High:49.05
Open:48.93
Low:48.17
Close:49.35
52wk High:61.70
52wk Low:42.85
Shares:2.02B
Float Shares:1.94B
Volume Ratio:1.87
T/O Rate:0.30%
Dividend:1.80
Dividend Rate:3.73%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.18
PE(LYR):12.89

Loading ...

Drug Pricing Pressure Puts GSK And Global Pharma Stocks In Focus

Simply Wall St.
·
Jul 07

GSK Falls Monday, Underperforms Market

Dow Jones
·
Jul 07

Pharmaceutical Sector Attracts Capital Rotation, GlaxoSmithKline Surges Nearly 5%

Stock News
·
Jul 02

Movement Alert|GSK Rises 3.02% in Regular Trading, Pharma Sector Rallies as Nuvalent Tender Offer Advances

Market Focus
·
Jul 02

GSK Slides Wednesday, Underperforms Market

Dow Jones
·
Jul 02

GSK’s New mRNA Combo Shot Targets Flu and COVID-19 in One Vaccine

TIPRANKS
·
Jul 01

GSK: Neutral Stance Maintained as Near-Term Strength Offsets Pipeline and Litigation Risks; Price Target Held at £2,350

TIPRANKS
·
Jun 30

Goldman Sachs Sticks to Their Hold Rating for GlaxoSmithKline (GSK)

TIPRANKS
·
Jun 30

GSK Completes £2 Billion Share Buyback, Lifts Treasury Holdings to 6.7% of Voting Rights

TIPRANKS
·
Jun 29

J.P. Morgan Reaffirms Their Sell Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Jun 29

GlaxoSmithKline (GSK) Gets a Sell from Barclays

TIPRANKS
·
Jun 29

GSK’s Extended Salford Lung Study: What a Terminated Data Project Still Means for Investors

TIPRANKS
·
Jun 27

Dodge & Cox lifts GSK stake above 5% as institutional backing grows

TIPRANKS
·
Jun 26

GSK Advances BALANCE Trial: New IBS Drug Candidate Moves Through Mid‑Stage Testing

TIPRANKS
·
Jun 26

GSK’s MODIFY Asthma Trial: Early Biologic Bet With Long-Term Upside Potential

TIPRANKS
·
Jun 26

GSK Rallies Thursday, Outperforms Market

Dow Jones
·
Jun 26

GSK to Deliver Earnings Growth over Next Decade

Dow Jones
·
Jun 25

Gsk's HIV Franchise Seems Underappreciated

Dow Jones
·
Jun 25

Bernstein Reaffirms Their Buy Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Jun 25

GSK Revamps Belantamab Dosing in New Multiple Myeloma Study: What Investors Should Watch

TIPRANKS
·
Jun 25